These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 37094997)
1. Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up. Küchlin S; Ihorst G; Grotejohann B; Beisse F; Heinrich SP; Albrecht P; Ungewiss J; Wörner M; Hug MJ; Wolf S; Diem R; Lagrèze WA; Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37094997 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study. Lagrèze WA; Küchlin S; Ihorst G; Grotejohann B; Beisse F; Volkmann M; Heinrich SP; Albrecht P; Ungewiss J; Wörner M; Hug MJ; Wolf S; Diem R; Lancet Neurol; 2021 Dec; 20(12):991-1000. PubMed ID: 34800417 [TBL] [Abstract][Full Text] [Related]
3. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol. Diem R; Molnar F; Beisse F; Gross N; Drüschler K; Heinrich SP; Joachimsen L; Rauer S; Pielen A; Sühs KW; Linker RA; Huchzermeyer C; Albrecht P; Hassenstein A; Aktas O; Guthoff T; Tonagel F; Kernstock C; Hartmann K; Kümpfel T; Hein K; van Oterendorp C; Grotejohann B; Ihorst G; Maurer J; Müller M; Volkmann M; Wildemann B; Platten M; Wick W; Heesen C; Schiefer U; Wolf S; Lagrèze WA BMJ Open; 2016 Mar; 6(3):e010956. PubMed ID: 26932144 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Sühs KW; Hein K; Sättler MB; Görlitz A; Ciupka C; Scholz K; Käsmann-Kellner B; Papanagiotou P; Schäffler N; Restemeyer C; Bittersohl D; Hassenstein A; Seitz B; Reith W; Fassbender K; Hilgers R; Heesen C; Bähr M; Diem R Ann Neurol; 2012 Aug; 72(2):199-210. PubMed ID: 22926853 [TBL] [Abstract][Full Text] [Related]
5. Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin. Sühs KW; Papanagiotou P; Hein K; Pul R; Scholz K; Heesen C; Diem R Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706045 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin. Shayegannejad V; Shahzamani S; Dehghani A; Dast Borhan Z; Rahimi M; Mirmohammadsadeghi A Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):797-801. PubMed ID: 25605544 [TBL] [Abstract][Full Text] [Related]
7. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Raftopoulos R; Hickman SJ; Toosy A; Sharrack B; Mallik S; Paling D; Altmann DR; Yiannakas MC; Malladi P; Sheridan R; Sarrigiannis PG; Hoggard N; Koltzenburg M; Gandini Wheeler-Kingshott CA; Schmierer K; Giovannoni G; Miller DH; Kapoor R Lancet Neurol; 2016 Mar; 15(3):259-69. PubMed ID: 26822749 [TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247 [TBL] [Abstract][Full Text] [Related]
10. Corticosteroids for treating optic neuritis. Gal RL; Vedula SS; Beck R Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001430. PubMed ID: 26273799 [TBL] [Abstract][Full Text] [Related]
11. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485 [TBL] [Abstract][Full Text] [Related]
12. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. Tourbah A; Gout O; Vighetto A; Deburghgraeve V; Pelletier J; Papeix C; Lebrun-Frenay C; Labauge P; Brassat D; Toosy A; Laplaud DA; Outteryck O; Moreau T; Debouverie M; Clavelou P; Heinzlef O; De Sèze J; Defer G; Sedel F; Arndt C CNS Drugs; 2018 Jul; 32(7):661-672. PubMed ID: 29808469 [TBL] [Abstract][Full Text] [Related]
13. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Optic Neuritis Study Group Ophthalmology; 2008 Jun; 115(6):1079-1082.e5. PubMed ID: 17976727 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. Pakravan M; Esfandiari H; Sanjari N; Ghahari E Am J Drug Alcohol Abuse; 2016 Nov; 42(6):633-639. PubMed ID: 27463192 [TBL] [Abstract][Full Text] [Related]